AbbVie ( ABBV 0.64%) is a leader in biopharmaceuticals with a product portfolio spanning multiple therapeutic areas, ...
Sam Finn, a senior research associate at Zymo Research working with the Oncology Diagnostic Team, helped to host this interactive game booth at the “BioFestival” on Tuesday.
The biotech scene can be seen as fairly risky for new investors who want to put money to work. After all, it's really tough to gauge which innovative biotech firms will have something genuinely ground ...
makes biotech firms very intriguing for those seeking a timelier trend to ride higher. As more data comes in, perhaps Lilly and the company can stay at the top of their game as new offerings aim ...
makes biotech firms very intriguing for those seeking a timelier trend to ride higher. As more data comes in, perhaps Lilly and the company can stay at the top of their game as new offerings aim ...